sCD36 as a Biomarker for Progression and Recurrence in Type 2 Diabetes Mellitus Associated Hepatocellular Carcinoma
This study was registered in September 2024 with the Chinese Clinical Trial Registry (ChiCTR), registration number: ChiCTR2400089651.
Authors
- Anhua Xiao
- Deying He
- Fucheng Guo (ORCID: https://orcid.org/0000-0002-9256-385X)
- Jiajia Zhang (ORCID: https://orcid.org/0000-0003-4566-0822)
- Ying Guo (ORCID: https://orcid.org/0000-0002-5836-1816)
- Yuling Ding
- Yingying Gao (ORCID: https://orcid.org/0000-0002-6601-5040)
- Weiwei Dai
- Fan Yang (ORCID: https://orcid.org/0000-0002-8111-4880)
Institutions
- Jiamusi University (CN)
- Dalian Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- First Affiliated Hospital of Jiamusi University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2025-11-01
- DOI
- https://doi.org/10.2147/jhc.s565006
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00